Physician profile
Edgar U Ekure
NPI 1891094488
$1,468.06
in general payments reported to CMS, 2019-2025
16 companies · $52.48 in 2025
The $52.48 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $49.00 · 2021: $169 · 2022: $522 · 2023: $443 · 2024: $84.53 · 2025: $52.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $577.58 | 2021-2024 | Precision 1, Rocklatan |
| Novartis Pharmaceuticals Corporation | $158.68 | 2019-2023 | |
| Dompe US, INC. | $133.03 | 2022-2023 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $120.39 | 2023 | |
| Biotissue Holdings INC. | $112.05 | 2019-2022 | |
| Oyster Point Pharma, INC. | $79.08 | 2022-2023 | Tyrvaya |
| Astellas Pharma US INC | $51.36 | 2024-2025 | Izervay |
| Allergan, INC. | $49.00 | 2020 | |
| Coopervision INC. | $36.07 | 2024 | Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $32.20 | 2019 | |
| Abbvie INC. | $22.05 | 2022 | |
| Kala Pharmaceuticals, INC. | $21.43 | 2022 | |
| Shire North American Group INC | $20.48 | 2019 | |
| Lkc Technologies, INC. | $20.42 | 2025 | |
| Bausch & Lomb Americas INC. | $18.19 | 2023 | Alrex, Vyzulta, Zylet |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.05 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Ekure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.